535
Participants
Start Date
November 30, 2011
Primary Completion Date
June 30, 2014
Study Completion Date
June 30, 2014
48-weeks course
patients receive a dose of 180 µg of PEGASYS once a week for 48 weeks
Ribavirin
patients receive a dose 800 to 1200 mg of ribavirin once a day(according to weight) for 48 weeks
Peginterferon alfa2a
patients receive a dose of 180 µg of PEGASYS once a week for 24 weeks
Ribavirin
patients receive a dose 800 to 1200 mg of ribavirin once a day(according to weight) for 24 weeks
The Eighth People's Hospital of Guangzhou, Guangzhou
The Third Affliated Hospital of Sun Yat-sen University, Guangzhou
Zhongshan second people's hospital, Zhongshan
Third Affiliated Hospital, Sun Yat-Sen University
OTHER